1. Home
  2. WHF vs PROF Comparison

WHF vs PROF Comparison

Compare WHF & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WHF

WhiteHorse Finance Inc.

HOLD

Current Price

$7.71

Market Cap

162.2M

Sector

Finance

ML Signal

HOLD

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$6.64

Market Cap

189.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WHF
PROF
Founded
2011
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
162.2M
189.2M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
WHF
PROF
Price
$7.71
$6.64
Analyst Decision
Sell
Strong Buy
Analyst Count
2
1
Target Price
$7.75
$11.00
AVG Volume (30 Days)
185.0K
99.4K
Earning Date
11-10-2025
11-13-2025
Dividend Yield
23.49%
N/A
EPS Growth
N/A
N/A
EPS
0.42
N/A
Revenue
$76,339,000.00
$14,297,000.00
Revenue This Year
N/A
$64.23
Revenue Next Year
N/A
$113.06
P/E Ratio
$17.92
N/A
Revenue Growth
N/A
67.94
52 Week Low
$6.39
$3.76
52 Week High
$11.31
$8.75

Technical Indicators

Market Signals
Indicator
WHF
PROF
Relative Strength Index (RSI) 63.20 55.13
Support Level $7.16 $6.09
Resistance Level $7.34 $7.04
Average True Range (ATR) 0.21 0.42
MACD 0.06 0.02
Stochastic Oscillator 89.19 61.00

Price Performance

Historical Comparison
WHF
PROF

About WHF WhiteHorse Finance Inc.

WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Share on Social Networks: